GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Dynasil Corp of America (OTCPK:DYSL) » Definitions » Net Change in Cash

Dynasil of America (Dynasil of America) Net Change in Cash : $-2.06 Mil (TTM As of Sep. 2019)


View and export this data going back to 2000. Start your Free Trial

What is Dynasil of America Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Dynasil of America's Net Change in Cash for the three months ended in Sep. 2019 was $-0.25 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2019 was $-2.06 Mil.

Dynasil of America Net Change in Cash Historical Data

The historical data trend for Dynasil of America's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dynasil of America Net Change in Cash Chart

Dynasil of America Annual Data
Trend Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.55 1.31 -0.19 -0.09 -2.06

Dynasil of America Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.82 -1.16 -0.82 0.17 -0.25

Dynasil of America Net Change in Cash Calculation

Dynasil of America's Net Change in Cash for the fiscal year that ended in Sep. 2019 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.508+-0.893+-0.625+-0.033
=-2.06

Dynasil of America's Net Change in Cash for the quarter that ended in Sep. 2019

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=1.443+-0.214+-1.471+-0.009
=-0.25

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dynasil of America Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Dynasil of America's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Dynasil of America (Dynasil of America) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Dynasil Corp of America (OTCPK:DYSL) » Definitions » Net Change in Cash
Comparable Companies
UCLE MIND MEEC IMLE ELSE BNSO SCND SMIT LCTC FLXT TSE:6861 FTV KEYS OSTO:HEXA B GRMN TDY CGNX HICTF TSE:8036 TRMB
Traded in Other Exchanges
N/A
Address
313 Washington Street, Suite 403, Newton, MA, USA, 02458
Website
https://www.dynasil.com
Dynasil Corp of America is a US-based company. It operates in three segments. The Optics segment, which is the key revenue driver, encompasses Dynasil Fused Silica, Evaporated Metal Films, Hilger Crystals, and Optometrics. It manufactures commercial products, including optical crystals for sensing in the security and medical imaging markets, and optical components, optical coatings and optical materials for scientific instrumentation and other applications. The Innovation and Development segment consists of the Radiation Monitoring Devices. The Biomedical segment consists of Dynasil Biomedical, a medical technology incubator that owns rights to certain early-stage medical technologies.
Executives
Bowdring Robert Joseph Jr officer: Former CFO 92 GOULD STREET, WAKEFIELD MA 01880
Alan B Levine director
Lawrence Joseph Fox director C/O ABERDEEN ASSET MANAGEMENT INC., 1735 MARKET STREET - 32ND FLOOR, PHILADELPHIA PA 19103
Craig T Dunham director, 10 percent owner DYNASIL CORPORATION, 385 COOPER ROAD, WEST BERLIN NJ 08091
David Kronfeld director JK&B CAPITAL, 180 N. STETSON AVENUE, SUITE 4500, CHICAGO IL 60601
Thomas C Leonard director KADANT INC., 1 TECHONOLOGY PARK DRIVE, WESTFORD MA 01886
Gerald Entine 10 percent owner 100 BELVIDERE STREET, SUITE 10B, BOSTON MA 02199